French Observatory of Rare Malignant Tumors of the Ovary

Completed

• Conditions: Ovarian Tumors

• Registration Number: NCT01304043
• Lead Sponsor: ARCAGY/ GINECO GROUP

Brief Summary

To take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.

Detailed Description

* to establish prognosis factors for the disease

* to proceed in a centralised examination of histologic laminas

* to reach in the long-term and homogenous follow-up of the patients

* to follow-up the long-term toxicities of the treatments given

* to analyse and follow-up the later fertility of the patients

* to evaluate the interest of setting a multi-disciplinary discussion forum on the Web

Study Timeline

• Study Start: 2002-01
• Study First Submitted: 2005-09-09
• Study First Submitted QC: 2011-02-24
• Study First Posted: 2011-02-25
• Study Completion: 2011-06
• Status Verified: 2012-04
• Last Update Submitted: 2012-04-19
• Last Update Posted: 2012-04-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 204

Inclusion Criteria

• age > 18 years old
• germinal or sexual cords ovary tumors histologically proven
• first line or relapse treatment
• written informed consent

Exclusion Criteria

• mental ineptitude to understand and follow the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Oncologie, Hôtel-Dieu, 1 place du parvis Notre-Dame; 🇫🇷 Paris, France